CGS International Accelerates Sustainability Efforts and Unveils Second Sustainability Report
"CGS International remains committed to future-proofing our business by embedding sustainability in our strategy. We are focused on creating long-term value for our stakeholders and giving back to the communities we serve.
At the same time, we continue to facilitate capital flows between China and ASEAN, some of which could be channeled to sustainable development areas that address climate and biodiversity risks in the ASEAN region," said Ms Carol Fong, Group CEO of CGS International.
Promoting Bilateral Relations and Mutual Growth
In an increasingly fragmented and volatile global economy, it is important for Asian countries to forge closer regional cooperation to increase collective influence and trade resilience. The Group strengthened its role as a China-ASEAN nexus, facilitating not only capital flows, but also bilateral relations. In 2024, several high-impact conferences were organised across Southeast Asia and China, including the CGS SEA Bilateral Investment Forum 2024 in Hainan, which brought over 300 business leaders from China and ASEAN together. The Group also fostered closer relations between China and Malaysia, including a letter of intent between the governments of Hangzhou and Kuala Lumpur, and hosting high-level delegates to deepen bilateral cooperation.
A notable initiative within the Group was the launch of a secondment programme between CGS International and its parent company, China Galaxy Securities, with the aim to facilitate cross-cultural exchanges and strengthen intra-group ties.
Deepening ESG Integration Across the Group
The 2024 report highlights meaningful progress across the Group's 8SF areas and marks a milestone in its Vision 2025 Strategy and Business Plan, the five-year roadmap that places sustainability at the heart of its strategic direction:
In 2024, CGS International advanced its "Sustainable Finance" focus by introducing the ESGIF, developed and endorsed by the Group's Sustainability Committee. This framework aims to provide direction and harmonisation for the development of ESG products and services. It establishes clear mechanisms for measurement, tracking, and reporting to support strategic decision-making.
Furthermore, CGS International's Malaysia office launched ESG Margin Financing to promote investment in companies with strong ESG performance. Customers investing in constituents of the FTSE4Good Bursa Malaysia Index with high ESG ratings received preferential financing rates, with total loans extended reaching RM4.88 million. The Group's presence in Shariah-compliant markets across ASEAN also drove over S$6 million in revenue from faith-based products.
Fostering Collaborative Impact
"At CGS International, we believe that knowledge sharing and collaboration are essential to driving meaningful progress on critical sustainability issues. By working closely with our partners and stakeholders, we aim to create a stronger collective catalyst for sustainable finance across Southeast Asia, and mobilise the industry towards greater climate action across ASEAN," said Mr Kevin Lee, Group Head of Sustainability.
One such initiative is the ASEAN Institute of Carbon Neutrality ("AICN"), launched in late 2023. AICN aspires to mobilise capital towards sustainable development in the ASEAN region to address issues such as climate change. This is done through education and engagement with the business community on sustainability issues through knowledge sharing and thought leadership. The AICN has collaborated with the Sustainable and Green Finance Institute ("SGFIN") from the National University of Singapore since 2024, which resulted in two white papers published on the topics, Just Energy Transition Partnership in Indonesia and Renewable Energy Imports for Singapore. AICN also hosted two webinars on related topics in 2024, including one on nature-related risks for corporates. In the pipeline are three joint research reports with SGFIN in 2025.
- END -
About CGS International Securities
CGS International Securities Pte. Ltd. ("CGS International") is an award-winning and market leading integrated financial services provider, ranked among the top securities houses in Asia.
CGS International taps on our wealth of global and ASEAN insights to offer equities trading, leveraged products, wealth management, investment banking, equities research, Shariah-compliant financing, fixed income, currency and commodities, structured products and prime brokerage services in over 15 countries and regions.
Along with its parent organisation China Galaxy Securities, a leading securities house in China, CGS International is trusted by close to 18 million customers globally.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
7 hours ago
- Korea Herald
CeraVe Celebrates Two Decades of "Developed with Dermatologists" Skincare: A 20th Birthday Tribute to Skin Barrier Science and Innovations
A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare Brand NEW YORK, July 23, 2025 /PRNewswire/ -- It's CeraVe-time to celebrate! CeraVe, the global skincare brand recommended by 80,000 dermatologists worldwide 1, is celebrating a major milestone: 20 years of skin barrier authority, championing barrier health and delivering effective, skin identical ceramide and MVE solutions to provide accessible, therapeutic skincare solutions for everybody everywhere. Over the past two decades, CeraVe has catapulted from a local US derm-backed secret to a global phenomenon, building an inclusive brand that appeals to all genders and generations. What remains unchanged is the brand's foundational insights: that most skin issues are linked to skin barrier disruption, and that skin identical ceramides are key to restoring and maintaining it. That insight began with three core products: Moisturizing Cream, Moisturizing Lotion and Hydrating Cleanser, and today powers a global portfolio of more than 90 barrier-supporting products. This unwavering dedication to its foundational insights, supported by its expertise as a skin barrier authority and its dermatologist-led development, has been the driving force behind CeraVe's remarkable exponential expansion, leading to an impressive 10X growth since its inception, and crossing the $2 billion mark in global sales last year. From the very beginning, CeraVe has revolutionized the skincare landscape as the first brand to be developed with dermatologists - not as a slogan, but as a guiding philosophy and scientific foundation. Every formula, every innovation, every product begins and ends with the expertise of dermatologists, from concept to counter (or store shelf); ensuring clinical efficacy, barrier health and results. "CeraVe's journey began and continues with dermatologists, ensuring superior skin health for all," said Melanie Vidal, Global General Manager, CeraVe. "Through close collaboration, we've transformed their groundbreaking clinical insights into widely accessible, therapeutic solutions that truly enhance lives. As we celebrate two decades of CeraVe and our significant expansion into over 65 countries, we are more dedicated than ever to formulating trusted, barrier-focused products, developed in partnership with dermatologists, for every individual. This momentous occasion not only honors our past achievements but also ignites our drive for another twenty years of pioneering global skin health and advancing the science of the skin barrier." Key to CeraVe's success is the unique formulation that pairs three skin-identical ceramides with trademarked MVE technology – a unique delivery system that releases ingredients gradually, providing hydration that goes 10 layers deep and lasts all day. From the beloved intense hydration of the AM & PM Facial Moisturizing Lotion for dry skin or the barrier-friendly approach of the new Anti-Dandruff Hydrating Shampoo and Conditioner, each product is a direct result of clinical insight and consumer need. This dedication to tailored, dermatologist-developed solutions, consistently infused with ceramides and MVE technology, is why CeraVe has earned such profound trust and widespread recommendations from skin health professionals worldwide. Indeed, in the US and Canada, CeraVe proudly holds the #1 recommended position among key healthcare professionals, including dermatologists, pharmacists, and pediatricians 2, underscoring its broad acceptance and efficacy across various medical specialties. To celebrate this significant accomplishment, CeraVe hosted a global celebration: a birthday bash in New York City that brought together some of the world's most-followed dermatologists, including Dr. Muneeb Shah, Dr. Mamina Turegano, Dr. Evan A. Rieder, Dr. Ted Lain, Professor Michael Cork, Dr. Esther Freedman, Dr. Dustin Portela, Dr. Wallace Nozile, Dr. Zoe Draelos, Dr. Nkem Ugonabo, Dr. Oyetewa Asempa, Dr. Leena Ramani, and Dr. Toral Vaidya, as well as some of TikTok's biggest stars, including Charli D'Amelio (@charlidamelio), and Ari@Home (@ariatinsta). The event was held on World Skin Health Day, allowing CeraVe to further amplify its message of accessible, dermatologist-developed skincare and its dedication to improving skin health worldwide, particularly through its commitment to providing access to dermatological care in under-resourced communities through the brand's Care For All social impact program. As CeraVe looks to the future, the brand remains steadfast in its commitment to dermatologist-developed, science-backed skincare solutions; it continuously pushes the boundaries of innovation. Recent launches highlight groundbreaking new formats within their comprehensive portfolio. For instance, the transformative Blemish Clay-to-Foam Cleanser offers a 3-in-1 solution for blemish-prone skin; it visibly reduces pimples and post-acne marks in just three days. The gentle cleansing Balancing Air Foam Facial Cleanser, designed for combination skin, features Breakthrough Glycolysine™ Technology, providing 8-Hour Oil Control and 24-Hour Hydration. Additionally, CeraVe Blemish Barrier Patches are now available; these leverage advanced hydrocolloid technology with 3 essential ceramides and niacinamide, visibly flattening blemishes in 3 hours, absorbing excess oil, and helping prevent post-acne marks. These innovations collectively underscore CeraVe's dedication to accessible and cutting-edge skincare for all. Beyond skincare, CeraVe marked a significant milestone in the past year by successfully entering the brand new hair care category with its Anti-Dandruff and Gentle Haircare lines. The CeraVe Anti-Dandruff Shampoo and Conditioner when used as a system eliminates up to 100% of visible flakes without disrupting the scalp barrier, while also alleviating symptoms of mild to moderate dandruff and leaving hair healthy and soft. This bold venture has notably been recognized as the most successful hair care launch according to Nielsen data 3. "As one of the first dermatologists involved in the development of CeraVe, I am proud to be part of a brand that has held true to their clinical roots," said Dermatologist Dr. Zoe Draelos. "CeraVe remains committed to involving dermatologists in the development and testing process – that's why it's one of the most effective skincare brands. It will be exciting to see the future brand innovations, as my fellow dermatologists continue to seek out accessible, beneficial skincare products for all." Beyond its scientific rigor, CeraVe has consistently engaged its audience through its signature "medutainment" style – a unique blend of education and entertainment – with a series of noteworthy campaigns over the past two decades. From the iconic Michael CeraVe Super Bowl commercial that playfully embraced the brand's name, to the destigmatizing of dandruff with the "Head of CeraVe" campaign, and most recently, its Sarah V. GOAT mascot, CeraVe has masterfully utilized these platforms to get its core messaging across and re-emphasize its status as a brand developed with dermatologists. 1 Source: Survey conducted among the dermocosmetic market carried out by APLUSA and its other partners between January 2024 and May 2024, involving dermatologists in 29 countries 2 Source: The #1 recommended positions are supported by the following: 3 Source: Nielsen Data About CeraVe: Founded in 2005 and developed with dermatologists, CeraVe is the first and only brand to offer a complete line of products containing essential ceramides and MVE technology to help restore the skin's natural protective barrier. CeraVe has a full line of skincare products to follow the dermatologist-recommended steps of: cleanse, treat, moisturize and protect. The brand's mission is to provide therapeutic skincare for all. For more information, visit the brand on Facebook (@ceraveusa), Instagram (@cerave), TikTok (@cerave), X (@cerave) or at
Korea Herald
7 hours ago
- Korea Herald
Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025
SEOUL, South Korea, July 23, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing system, CURECA™, and its data analytics platform, STAgora™, at ADLM 2025 (Association for Diagnostics & Laboratory Medicine), the world's largest diagnostics conference, taking place in Chicago from July 28 to 31. With the introduction of these new technologies, Seegene declares a transformative shift in the global diagnostics paradigm. Automating every step of PCR Testing for enhanced efficiency and accuracy CURECA™ is the world's first system to fully automate the entire PCR testing process – from specimen storage and pre-treatment to nucleic acid extraction, amplification, and result analysis – without any human intervention. Designed for 24/7 continuous operation, the system minimizes human error and dramatically improves the consistency and reliability of the test results. A key breakthrough lies in its fully automated prep module, which addresses one of the most burdensome and error-prone stages in diagnostic workflows. Pre-treatment has traditionally been a major challenge, particularly when dealing with diverse sample types such as urine, blood, sputum, and stool. Lab technicians often carry out repetitive manual tasks over extended hours, and variations in skill level can result in inconsistent outcomes. Stool samples, especially, have posed serious automation barriers due to their viscosity and particulates, requiring heavy manual handling. The prep module of CURECA™ system is the first to fully automate pre-treatment process across all major specimen types – including stool – overcoming longstanding obstacles in laboratory operations. This innovation reduces labor demands, expands sample throughput, and enhances overall operational and cost efficiency. It also shifts the role of laboratory personnel from manual processing to higher-level responsibilities, such as data analysis and clinical interpretation – helping labs better leverage their workforce in high-volume testing environments. In addition, the prep module is applicable beyond PCR diagnostics. It supports pre-treatment for other disciplines, including clinical chemistry and immunoassays, marking a significant step forward in automation across the broader diagnostics market. Its modular architecture allows for flexible configuration and deployment tailored to the size, layout, and needs of each laboratory. STAogra ™ – Real-Time Global Data Integration Empowering Personalized Care Also unveiled at ADLM 2025, STAgora™ is Seegene's statistical platform that collects and analyzes real-time PCR diagnostic data to support clinical decision-making. By aggregating test data uploaded from hospitals around the world, the platform provides integrated insights into regional infection trends, hospital-level positivity rates, and patterns of co-infection. It also offers more than 40 statistical tools tailored for clinical support. With STAgora™, healthcare providers can compare individual patient test results with local and regional epidemiological data, enabling more precise, data-driven treatment strategies. The platform allows clinicians to evaluate infection trends at both patient and community levels, improving the accuracy and speed of diagnosis and care planning. By delivering rapid, reliable insights through this kind of comprehensive analysis, STAgora™ is expected to become an essential analytical tool for clinical decision-making. Expanding Global Collaboration via Technology Sharing and Strategic Partnerships Building on its presence at ADLM 2025, Seegene aims to broaden access to CURECA™ and STAgora™ by offering early pilot experiences and establishing new global partnerships. Earlier this year, CURECA™ attracted strong interest at ESCMID Global 2025, one of Europe's leading clinical microbiology and infectious disease congresses. To strengthen its R&D and manufacturing capacity in the United States, Seegene has established local subsidiaries, including Seegene Technologies and Seegene CURECA. "CURECA™ and STAgora™ are more than just diagnostics equipment or software—they represent a new global standard that will redefine diagnostics in clinical settings around the world. We will continue to share the many technological assets we've built over the years and based on this foundation, we are committed to driving fundamental innovation across the global diagnostics ecosystem." Said Daniel Shin, Executive Vice President, Chief of Global Sales & Marketing at Seegene. Disclaimer The product is currently in a pre-commercialization phase. The configuration presented at ADLM 2025 is for demonstration purposes only and may differ in functionality, specifications, and components from the final commercial version. This material is intended solely to introduce the technology and does not constitute an advertisement for product sales. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information.
Korea Herald
8 hours ago
- Korea Herald
Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025
SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will take place in Shanghai, China, from September 9–12, 2025, co-hosted by Chinese Stomatological Association and Reed Sinopharm Exhibitions. Organized annually in different countries, the WDC highlights the importance of oral health in securing overall health and well-being and serves as a driving force for international collaboration in dentistry. In recent years, visa-free policies have made China an increasingly popular destination for global travelers. This enhanced accessibility, coupled with Shanghai's global appeal, and FDI's established reputation as the leading global dental event, has already attracted over 10,000 congress delegates for the 2025 edition, with expectations of more than 35,000 professional attendees and visitors from 134 countries and regions. Attendees can look forward to a robust scientific program packed with insights from over 300 world-class speakers and interactive forums on key dental topics. Meanwhile, the FDI WDC 2025 Exhibition is set to be the largest in FDI history, featuring 700 selected exhibitors across 60,000 square meters. Leading global brands such as Haleon, Listerine, LION, and Colgate, along with hundreds of Chinese manufacturers and technology providers, will showcase the most advanced dental equipment and solutions. The exhibition will also spotlight achievements from hospitals and universities, innovations in AI-powered diagnostics, digital dentistry, and 3D printing, providing state-of-the-art solutions to participants. Additionally, the Congress promises exceptional networking opportunities through guided tours designed to connect researchers, clinicians, industry experts, and distributors, fostering partnerships that can advance oral health globally. A Social Program to Remember The social program accompanying WDC25 will provide attendees with a unique cultural experience. Highlights include the Opening Ceremony on September 9, and the Gala Dinner on September 10 invites guests to immerse themselves in Chinese heritage through live performances, regional cuisine, and an evening celebrating cultural elegance. Shanghai Night set for September 11, will be held along the iconic Bund, offering a memorable evening of live music, handcrafted cocktails, and stunning views of Shanghai's dynamic skyline. These events perfectly capture the city's vibrant "East-meets-West" charm and cultural essence. China's Emergence as a Dental Destination While the Congress takes center stage, China's rise as a key market for dentistry cannot be overlooked. Since 2006, China's dental sector has experienced unprecedented growth, outpacing most global markets. The sector's technological transformation has been equally impressive. Chinese dental practices have rapidly adopted cutting-edge solutions including fully digital workflows, fundamentally enhancing treatment accuracy, efficiency, and patient comfort - setting new standards for dental care delivery. Driving Global Oral Health Forward The FDI World Dental Congress continues to set the benchmark for advancing oral health on the global stage. By uniting leaders from across the dental profession, WDC25 will showcase dentistry's most pressing innovations, address key health challenges, and foster greater collaboration to improve oral care around the world.
